Registry for childhood and young adult cancer patients
UNC Childhood, Adolescent, and Young Adult Cancer Cohort
This study is creating a registry for young cancer patients to track their health and well-being over time and help improve future care.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 500 (estimated) |
| Ages | 1 Year to 39 Years |
| Sex | All |
| Sponsor | UNC Lineberger Comprehensive Cancer Center Academic / other |
| Locations | 1 site (Chapel Hill, North Carolina) |
| Trial ID | NCT05096923 on ClinicalTrials.gov |
What this trial studies
This study aims to establish a registry for patients diagnosed with cancer at age 40 or younger, focusing on those treated during adolescence and young adulthood. Participants will undergo various assessments, including physical and cognitive evaluations, health-related quality of life questionnaires, and body composition measurements. Additionally, biospecimens will be collected for biobanking to support ongoing cancer outcomes research. The registry will track participants from diagnosis through treatment and into survivorship to better understand their long-term health outcomes.
Who should consider this trial
Good fit: Ideal candidates are individuals aged 0-39 years at the time of cancer diagnosis who are currently in treatment or survivorship.
Not a fit: Patients who are unwilling to provide informed consent or speak a language other than English or Spanish may not benefit from this study.
Why it matters
Potential benefit: If successful, this registry could enhance understanding of cancer outcomes and improve care for pediatric and young adult cancer survivors.
How similar studies have performed: Other studies focusing on cancer registries for young patients have shown promise in improving understanding of treatment outcomes and survivorship issues.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient ages 0-39 years at the time of cancer diagnosis (ages 1-39 years at enrollment) who are at any point in treatment and survivorship trajectory * English or Spanish speaking Exclusion Criteria: * Unwilling to sign informed consent * Speak a language other than English or Spanish.
Where this trial is running
Chapel Hill, North Carolina
- University of North Carolina at Chapel Hill — Chapel Hill, North Carolina, United States (Recruiting)
Study contacts
- Principal investigator: Andrew Smitherman, MD — University of North Carolina, Chapel Hill
- Study coordinator: Andrew Smitherman, MD
- Email: andrew_smitherman@med.unc.edu
- Phone: 919-966-1178
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.